Message from Nelson Hardiman:

We are living through a public health crisis as the coronavirus (COVID-19) pandemic spreads across the globe. At Nelson Hardiman, we have been fielding calls nonstop in recent weeks from organizations struggling with emerging issues, including decisions about how to respond to the evolving risks, the need for new policies to address safety challenges, and privacy concerns fueled by a demand for information on infectious disease risks.

Nelson Hardiman is committed to the health and wellbeing of our entire community. We are standing shoulder to shoulder with the healthcare community in responding to the crisis presented by COVID-19. What does that mean?

  1. Nelson Hardiman remains open and hard at work. Our team is responding to the needs of healthcare providers –hospitals, telehealth providers, product manufacturers, senior care providers, labs, pharmacies, physician practices, and more – as well as other organizations addressing workforce and health issues. Whatever points of confusion or new questions around COVID-19 you are experiencing, we are here to help.
  1. Nelson Hardiman will be sharing content in the coming weeks and months as the situation evolves to provide updates and resources on emerging issues presented by COVID-19. If you have ideas about what you would like to know, we are open to your suggestions. Please email [email protected].
  1. In the interim, we encourage everyone to regularly visit the Center for Disease Control and Prevention (CDC) Coronavirus resource page for best practices and essential information. We also recommend the World Health Organization (WHO) resources.

We will be providing more information ahead. In this difficult time, we send our prayers for you, your family, friends, and communities to be safe and healthy.

Nelson Hardiman, LLP.

COVID-19 Resources (last updated 4/2/2020)

Our COVID-19 resource page includes federal and state resources on COVID-19 and will be updated over the course of this crisis to keep you informed of the latest developments.

For further information, please contact Harry Nelson at [email protected]

For media inquiries, please contact Jennifer Coren at [email protected]

Federal Resources

Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, Pub. L. 116-123 (3/6/20) (Provides $8.3 billion in emergency funding for federal agencies to respond to COVID-19 outbreak and providing waiver authority for Medicare coverage of telehealth services during certain emergencies).

CMS:

Including:

  • Information to Medicare Advantage Organizations Related to COVID-19 (3/10/20).
  • Dialysis Facilities:  QSO-20-19-ESRD, Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in dialysis facilities (3/10/20).
  • Home Health:  QSO-20-18-HHA, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs) (3/10/20).
  • Respirators:  QSO-20-17-ALL, Guidance for use of Certain Industrial Respirators by Health Care Personnel (3/10/20).
  • Hospice:  QSO-20-16-Hospice, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) by Hospice Agencies (3/9/20).
  • EMTALA:  QSO-20-15 Hospital/CAH/EMTALA, Emergency Medical Treatment and Labor Act (EMTALA) Requirements and Implications Related to Coronavirus Disease 2019 (COVID-19) (3/9/20).
  • Nursing Homes:  QSO-20-14-NH Revised 3/13/20, Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in nursing homes (revised 3/9/20).  CMS Announces New Measures to Protect Nursing Home Residents  from COVID-19 (3/13/20).
  • Hospitals:  QSO-20-13-Hospitals, Guidance for Infection Control and Prevention Concerning Coronavirus Disease (COVID-19): FAQs and Considerations for Patient Triage, Placement and Hospital Discharge (3/4/20).
  • QSO-20-12-All, Suspension of Survey Activities (3/4/20)
  • QSO-20-10-CLIA, Notification to Surveyors of the Authorization for Emergency Use of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel Assay and Guidance for use in CDC Qualified Laboratories (2/6/20).
  • QSO-20-09-ALL, Information for Healthcare Facilities Concerning 2019 Novel Coronavirus Illness (2019-nCoV) (2/6/20).

CDC

 California Resources

California Department of Public Health

Including CDPH All Facilities Letters:

Telehealth Resources

Other